Accumulating studies showed that apigenin (50 μM) could inhibit GBM cell proliferation and migration by inducing oxidative stress [282], cell cycle arrest, and regulating c-Met signaling at 25 μM [283], and apoptosis pathway [180,284]. Here, MET is linked to glioblastoma.